Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Class of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC
March 10, 2025
Via
TheNewswire.com
Tickers
BICX
Exposures
Product Safety
Addressing Disparities in Liver Cancer Care
March 07, 2025
Via
Brandpoint
Topics
Death
Product Recall
Exposures
Death
Legal
Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Collaborates to Support Potential Accelerated Pathway for ALS Treatment Candidate
March 07, 2025
Via
Investor Brand Network
Tickers
CLNN
Exposures
Product Safety
The 10 Best Cities for Co-Warehousing in 2025
March 07, 2025
Via
Syndication Cloud
Topics
Product Recall
Exposures
Legal
Product Safety
Empowered by lived experience: How Lindsay and Matt found their voices in the narcolepsy community
March 07, 2025
Via
Brandpoint
Topics
Product Recall
Exposures
Legal
Product Safety
Plus Therapeutics Continues Rally On Friday - Here's Why
March 07, 2025
Via
Benzinga
Tickers
PSTV
Exposures
Product Safety
FDA Nominee Marty Makary Faces The Senate. Will He Toe The RFK Jr. Line?
March 06, 2025
Via
Investor's Business Daily
Tickers
MCD
MRNA
Exposures
Product Safety
FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray For Emergency Allergy Treatment
March 06, 2025
Via
Benzinga
Tickers
SPRY
Exposures
Product Safety
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Advances ADI-100 Autoimmune Therapy Toward Clinical Trials
March 06, 2025
Via
Investor Brand Network
Tickers
ADTX
APLIF
TSX:APLI
Exposures
Product Safety
Roots Farm Fresh Expands Allergen-Free Product Line Amid Rising Consumer Demand
March 06, 2025
Via
Press Release Distribution Service
Topics
Product Recall
Tickers
KR
Exposures
Legal
Product Safety
FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine
March 05, 2025
Via
Benzinga
Tickers
BNTX
Exposures
Product Safety
Why Is Hims & Hers Health Stock Trading Lower On Wednesday?
March 05, 2025
Via
Benzinga
Tickers
HIMS
NVO
Exposures
Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 Virtual Investor Summit
March 05, 2025
Via
Investor Brand Network
Tickers
TNXP
Exposures
Product Safety
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Via
NewMediaWire
Tickers
SIGY
Exposures
COVID-19
Product Safety
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Via
TheNewswire.com
Tickers
SIGY
Exposures
COVID-19
Product Safety
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
March 05, 2025
Via
Newsfile
Tickers
PHIO
Exposures
Product Safety
Capricor Therapeutics’ Retail Chatter Explodes On Stocktwits After FDA Grants Priority Review For DMD Therapy
March 04, 2025
Via
Stocktwits
Tickers
CAPR
IWM
VTI
XBI
Exposures
Product Safety
Lineus Medical Completes $4.6 Million Series C Funding Round
March 04, 2025
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
March 04, 2025
Via
Benzinga
Tickers
CAPR
Exposures
Product Safety
China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer
March 04, 2025
Via
Benzinga
Tickers
ONC
Exposures
Product Safety
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak
March 04, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
NNVC
Exposures
COVID-19
Intellectual Property
Product Safety
Tirzepatide Weight Loss Injections Savings Program: Eligibility Check Announced
March 04, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Luxenberg Garbett Kelly & George P.C. Addresses Memory Loss After an Accident in Pennsylvania
March 03, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Nourish House Calls: New Research Challenges Misconceptions About Hormone Therapy in Menopause Treatment
March 03, 2025
Via
Press Advantage
Exposures
Product Safety
GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review
March 03, 2025
Via
Benzinga
Tickers
GSK
Exposures
Product Safety
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
March 03, 2025
Via
Newsfile
Tickers
CSE:DMED
CSE:RVV
DGNMF
RVVTF
Exposures
Product Safety
PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
March 03, 2025
Via
Newsfile
Tickers
CSE:PHRM
PHRRF
Exposures
Product Safety
NADIOL Responds to NMN Supplement Industry Shake-Up: Committed to Quality, Transparency & Your Health
March 03, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
March 03, 2025
Via
Newsfile
Tickers
ELTP
Exposures
Product Safety
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) and OS Therapies (NYSE American: OSTX) to Appear on RedChip’s Bloomberg TV Show
February 28, 2025
Via
Investor Brand Network
Tickers
CLDI
OSTX
Exposures
Product Safety
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.